236 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (299)
- Addiction (4)
- Autoimmune Disorders (1)
- Blood Disorders (1)
- Cancer (27)
- COVID-19 (Coronavirus) (1)
- Ear, Nose and Throat (3)
- Endocrine & Metabolic Disease (1)
- (-) Eye (1)
- Healthy Volunteers (42)
- Heart Disease (1)
- Infectious Disease (2)
- Neurological Disorders (165)
- Obesity (1)
- Obstetrics & Gynecology (3)
- Pediatrics (10)
- Psychiatric Disorders (31)
- Rehabilitation (1)
- Stroke (1)
- Transplant (2)
- Vascular Conditions (1)
Displaying 1 - 2 of 2
Research Study of New Treatment Called NT-501 (Encapsulated Cell Therapy (ECT) Implant) for Glaucoma
Condition: Eye / Glaucoma
Investigator: George Cioffi, MD
Status: Closed
Glaucoma is a given name of a group of diseases that affect the retinal ganglion cells in the eye and the optic nerve. Glaucoma cause degeneration of the retinal ganglion cells in the retina and their projections (axons) that form the optic nerve. Retinal ganglion cells and their axons transmit all of our vision information from the eye to the…
Condition: Cancer / Pediatric Solid Tumors
Investigator: Stergios Zacharoulis, MD
Status: Closed
The purpose of this study is to find out more about how the study drug called entrectinib will be used in children, adolescents and young adults with treatment-resistant solid tumor in brain or body. This is a phase 1/1b study, divided into a dose escalation portion (different dose will be tested) and a dose expansion portion…